Remedy Health closes $11 million Series A funding round

3D printing technology powered startup Remedy Health has raised $11 million in Series A funding, bringing its valuation to $71.6 million.

Investors included ADM Ventures and Cibus Fund.

Remedy Health, which was formed in May 2019, also secured follow on investment from Apater Capital and Henkel X. 

The company develops 3D printing technologies to enable the production of personalised health and wellness solutions. It is best know for its gummy vitamin brand, Nourished.

Founder Melissa Snover says: “There has been a huge rise in the number of personalised nutrition products launched over the past few years, with the industry predicted to go from $3.7 billion in 2019 to over $16 billion in 2027.”

“Our goal is to offer truly personalised nutrition in a single daily format; we utilise our patented 3D printing technology to achieve this, something no one else in the world can do. We provide the highest quality active ingredients available to support every individual’s specific needs and goals.” 

“Remedy Health is ushering forward an entirely new era of true precision nutrition,” comments ADM Ventures lead Ian Pinner, Chief Strategy and Innovation Officer at ADM.

“The company’s 3D printed health and wellness solutions are helping the entire industry reimagine what’s possible, from truly personalised supplements to protein bars.”

“This is an area that ADM has long been focused, and we couldn’t be more ecstatic to invest in a company like Remedy Health, which is driving such significant advancements in nutrition, health and wellness.”  

Remedy Health is targeting 50,000 customers and over $10 million in sales in 2021, as well as expanding into curative health solutions.

Snover plans on using the Series A funds to further expand the Nourished portfolio, adding lines for kids and personalised protein bars to the range this year. She also hopes to build a production facility in the USA.

Sign up for our free retail technology newsletter here.